Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 7/20 | 0.94 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL25238730 | 1.00 | DNM1 (0.94) | DNM1TSHRALDH1A1THRBCA12 | |
| Fluoride SCHEMBL27688543 | 1.00 | DNM1 (0.94) | DNM1TSHRALDH1A1THRBCA12 | |
| Fluoride SCHEMBL20497333 | 1.00 | DNM1 (0.94) | DNM1TSHRALDH1A1THRBCA12 | |
| Fluoride SCHEMBL9450603 | 1.00 | DNM1 (0.94) | DNM1TSHRALDH1A1THRBCA12 | |
| Fluoride SCHEMBL17743529 | 1.00 | DNM1 (0.94) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL284680 | 0.97 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL1730438 | 0.97 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL119304 | 0.97 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| Dymanthine SCHEMBL61784 | 0.97 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL9807721 | 0.97 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3972698-B1 | ORAL COMPOSITIONS AND METHODS OF USE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-02-12 | — | — | EP | disclosed |
| EP-3463584-B1 | THERAPEUTIC DENTAL PASTES AND THE APPLICATION THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-27 | — | — | EP | disclosed |
| US-20230293393-A1 | NATURAL TOOTH POWDER TABLETS | MCCORMICK LINDSAY (US) | 2023-09-21 | — | — | US | disclosed |
| US-11701306-B2 | Natural tooth powder tablets | MCCORMICK LINDSAY (US) | 2023-07-18 | — | — | US | disclosed |
| US-11696879-B2 | Therapeutic dental pastes and related methods and kits | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-07-11 | — | — | US | disclosed |
| US-20220211603-A1 | Oral Compositions And Methods Of Use | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2022-07-07 | — | — | US | disclosed |
| US-20220192953-A1 | Oral Compositions And Methods Of Use | 3M INNOVATIVE PROPERTIES COMPANY | 2022-06-23 | — | — | US | disclosed |
| EP-3972557-A1 | ORAL COMPOSITIONS AND METHODS OF USE | 3M Innovative Properties Company (US) | 2022-03-30 | — | — | EP | disclosed |
| EP-3972698-A1 | ORAL COMPOSITIONS AND METHODS OF USE | 3M Innovative Properties Company (US) | 2022-03-30 | — | — | EP | disclosed |
| EP-0297212-B1 | ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1991-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11696879-B2 | Therapeutic dental pastes and related methods and kits | PROC, DNASE1, COL2A1 | DNM1 2086/4885TSHR 4358/4885ALDH1A1 1617/4885 |
| US-20220211603-A1 | Oral Compositions And Methods Of Use | MSR1, GCK, TAS2R40 | DNM1 3302/4885TSHR 838/4885ALDH1A1 4423/4885 |
| US-20220192953-A1 | Oral Compositions And Methods Of Use | HRH2, HRH3, HRH4 | DNM1 988/4885TSHR 1559/4885ALDH1A1 4776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.